BlackRock Global Funds - World Healthscience Fund D5

Category Sector Equity Healthcare
star-filledstar-filledstar-filledstar-filled
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

£14.58/£14.58

arrow-up£0.07 (+0.48%)

Fund Code

BGWDI

BK6KTX9

LU2112292763

Prices updated as at 12 Dec 2025
|
Prices in GBP
Investment objective
The Fund seeks to maximise total return and invest in a manner consistent with the principles of environmental, social and governance (“ESG”) investing. The Fund invests globally at least 70% of its total assets in the equity securities of companies whose predominant economic activity is in healthcare, pharmaceuticals, medical technology and supplies and the development of biotechnology. Currency exposure is flexibly managed.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Portfolio as of 31/10/2025

Asset allocation

Show long & short position

Geographical breakdown

Continent or country allocation (%)

Market classification (%)

Stock style

Large value

43.11%

% Weight
Value
Core
Growth
Large

43

25

12

Medium

5

10

4

Small

0

1

1

  • Interest rate risk

    Bond %
    Avg credit quality-
    Avg wtd coupon4.62
    Modified duration-

  • Credit quality breakdown

    Rating% of Bond
    No Data

Valuation

BlackRock Global Funds - World Healthscience Fund D5
Sector Equity Healthcare

17.63

17.63
18.97

1.65

1.65
1.92

4.12

4.12
4.17

13.09

13.09
13.61

Growth rate

BlackRock Global Funds - World Healthscience Fund D5
Sector Equity Healthcare

8.56%

8.56%
9.32%

1.85%

1.85%
1.51%

3.30%

3.30%
4.08%

Top 10 holdings

1
Johnson & Johnson
Sector
-
Country
United States
% of assets
8.02252
2
Eli Lilly and Co
Sector
-
Country
United States
% of assets
6.28977
3
AbbVie Inc
Sector
-
Country
United States
% of assets
5.657
4
Abbott Laboratories
Sector
-
Country
United States
% of assets
5.53849
5
AstraZeneca PLC
Sector
-
Country
United Kingdom
% of assets
5.12702
6
UnitedHealth Group Inc
Sector
-
Country
United States
% of assets
4.13821
7
Roche Holding AG
Sector
-
Country
Switzerland
% of assets
3.32481
8
Medtronic PLC
Sector
-
Country
United States
% of assets
3.16746
9
Thermo Fisher Scientific Inc
Sector
-
Country
United States
% of assets
2.99895
10
Novartis AG Registered Shares
Sector
-
Country
Switzerland
% of assets
2.76009
Assets in top 10 holdings %

47.02%

Total no. of equity holdings

86.00

Total no. of bond holdings

6.00

Stock sectors

BlackRock Global Funds - World Healthscience Fund D5
Sector Equity Healthcare

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

0.00%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

-
-

100.00%

Con defensive

-
-

Healthcare

100.00%
-

Utilities

-
-


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.